SEPTEMBER 9, 2022 by German Cancer Research Center Cancer cells often grow in environments that are low in nutrients, and they cope with this challenge by switching their metabolism to using proteins as alternative "food"....
ReadSEPTEMBER 8, 2022 by Weizmann Institute of Science Blood tests—simple, noninvasive and economically feasible—promise to become the next major milestone in cancer diagnosis. However, most of these tests, dubbed liquid biopsies, are currently not reliable...
ReadSEPTEMBER 7, 2022 by Case Western Reserve University Research led by Case Western Reserve University has identified a promising path to developing therapies to treat esophageal tumors––a form of cancer that not only is among...
ReadSEPTEMBER 6, 2022 by Brigham and Women's Hospital Over recent decades, more and more adults under the age of 50 are developing cancer. A study conducted by researchers from Brigham and Women's Hospital reveals that...
ReadSeptember 6, 2022 Report by Bob Yirka , Medical Xpress A pair of researchers, one with the Harvard T.H. Chan School of Public Health, the other with the University of North Carolina, Chapel Hill, are...
ReadSEPTEMBER 2, 2022 by Bendta Schroeder, Massachusetts Institute of Technology “Machine learning tools like this one could empower oncologists to choose more effective treatments and give more guidance to their patients,” says Koch Institute clinical...
ReadSEPTEMBER 1, 2022 by The Mount Sinai Hospital Mount Sinai researchers report encouraging immunotherapy option for relapsed myeloma patients Treatment breakdown of the multiple myeloma patient cohort. (A) Flow chart showing that the initial retrospective...
ReadAUGUST 31, 2022 by Sarah Avery, Duke University In animal studies led by researchers at Duke Cancer Institute, a drug approved to treat leukemia successfully disrupted the ability of HER2-positive breast cancer tumors from colonizing...
Readby Karolinska Institutet Esophageal cancer is the seventh most common cancer worldwide and a lethal malignancy causing a considerably high number of deaths. There is currently no promising method for prevention, early detection, or screening...
ReadAUGUST 27, 2022 by Richard Harth, Arizona State University Therapeutic viruses help turbocharge the immune system against cancer The illustration shows a cancer cell (center) surrounded by immune T-cells augmented with an oncolytic (cancer-fighting) virus....
ReadAUGUST 26, 2022 by Children's Hospital Los Angeles A recent study reveals differences in how symptom toxicity is reported for children receiving cancer treatment in clinical trials. Doctors often underestimate or miss a child's symptoms,...
ReadAUGUST 25, 2022 by University of California, Los Angeles Restoring normal functioning in the brains of cancer patients through neurofeedback could potentially alleviate the mental fogginess that many report after treatment, according to a new...
ReadAUGUST 24, 2022 by St. Jude Children's Research Hospital More-effective therapies are greatly needed for children with high-risk blood cancer T-cell acute lymphoblastic leukemia (T-ALL). St. Jude Children's Research Hospital scientists have leveraged the latest...
ReadAUGUST 23, 2022 by Institute of Cancer Research Long-term benefit of radiotherapy confirmed in advanced prostate cancer Treated prostate cancer cells. Credit: Mateus Crespo/Professor Johann de Bono, the ICR Radiotherapy to the prostate alongside standard...
ReadAUGUST 22, 2022 by University of Leeds The deadliest form of brain cancer returns because tumors adapt to treatment by recruiting help from nearby healthy tissue, say researchers who are trying to find a cure...
ReadNearly half of cancers worldwide can be traced back to a known risk factor, primarily tobacco or alcohol, a huge global study found on Friday, which said that behavioral changes can help reduce the threat...
ReadJULY 18, 2022 by Umea University Prostate cancer is the most common form of cancer in males in Sweden. Researchers at Umeå University have now discovered a faster and easier way to determine who has...
ReadJULY 14, 2022 by University of Texas M. D. Anderson Cancer Center In a study of patients with borderline resectable pancreatic cancer, combination chemotherapy with modified FOLFIRINOX before surgery increased survival relative to historical data...
ReadJULY 13, 2022 by CORDIS When cancer cells break away from the original tumor in metastatic—stage IV—breast cancer, they usually spread to the bones, liver, or lungs. A new study, associated with the MetEpiStem project,...
ReadJULY 12, 2022 By Dennis Thompson The U.S. Supreme Court's decision to overturn Roe v. Wade will limit cancer treatment options for pregnant women and put lives needlessly at risk, America's leading cancer societies warn....
Read